27098-98-2,MFCD01721366
Catalog No.:AA00CE2X

27098-98-2 | 2-Methanesulfonyl-1h-imidazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
2 weeks  
$170.00   $119.00
- +
250mg
98%
2 weeks  
$258.00   $181.00
- +
1g
97%
2 weeks  
$622.00   $436.00
- +
5g
97%
2 weeks  
$1,541.00   $1,079.00
- +
10g
97%
2 weeks  
$2,590.00   $1,813.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00CE2X
Chemical Name:
2-Methanesulfonyl-1h-imidazole
CAS Number:
27098-98-2
Molecular Formula:
C4H6N2O2S
Molecular Weight:
146.1676
MDL Number:
MFCD01721366
SMILES:
CS(=O)(=O)c1ncc[nH]1
NSC Number:
222403
Properties
Computed Properties
 
Complexity:
181  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-0.4  

Downstream Synthesis Route

[1]Nagarajan,K.;Arya,V.P.;Shah,R.K.;Shenoy,S.J.;Bhat,G.A.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1982,vol.21,#10,p.945-948]

[1]Locationinpatent:schemeortableZhu,Yuping;Olson,StevenH.;Hermanowski-Vosatka,Anne;Mundt,Steven;Shah,Kashmira;Springer,Marty;Thieringer,Rolf;Wright,Samuel;Xiao,Jianying;Zokian,Hratch;Balkovec,JamesM.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#11,p.3405-3411]

Literature

Title: Synthesis and cloxacillin antimicrobial enhancement of 2-methylsulfonylimidazolyl-1,4-dihydropyridine derivatives.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20100101

Title: Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.

Journal: Arthritis research & therapy 20050101

Title: Genetic algorithm applied to the selection of factors in principal component-artificial neural networks: application to QSAR study of calcium channel antagonist activity of 1,4-dihydropyridines (nifedipine analogous).

Journal: Journal of chemical information and computer sciences 20030101

Title: Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method.

Journal: Archiv der Pharmazie 20021201

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 27098-98-2
Tags:27098-98-2 Molecular Formula|27098-98-2 MDL|27098-98-2 SMILES|27098-98-2 2-Methanesulfonyl-1h-imidazole
Catalog No.: AA00CE2X
27098-98-2,MFCD01721366
27098-98-2 | 2-Methanesulfonyl-1h-imidazole
Pack Size: 100mg
Purity: 98%
2 weeks
$170.00 $119.00
Pack Size: 250mg
Purity: 98%
2 weeks
$258.00 $181.00
Pack Size: 1g
Purity: 97%
2 weeks
$622.00 $436.00
Pack Size: 5g
Purity: 97%
2 weeks
$1,541.00 $1,079.00
Pack Size: 10g
Purity: 97%
2 weeks
$2,590.00 $1,813.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00CE2X
Chemical Name: 2-Methanesulfonyl-1h-imidazole
CAS Number: 27098-98-2
Molecular Formula: C4H6N2O2S
Molecular Weight: 146.1676
MDL Number: MFCD01721366
SMILES: CS(=O)(=O)c1ncc[nH]1
NSC Number: 222403
Properties
Complexity: 181  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 9  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -0.4  
Downstream Synthesis Route
27098-98-2    1615-53-8    85868-82-2 

[1]Nagarajan,K.;Arya,V.P.;Shah,R.K.;Shenoy,S.J.;Bhat,G.A.[IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1982,vol.21,#10,p.945-948]

1042443-53-7    27098-98-2    1042443-42-4 

[1]Locationinpatent:schemeortableZhu,Yuping;Olson,StevenH.;Hermanowski-Vosatka,Anne;Mundt,Steven;Shah,Kashmira;Springer,Marty;Thieringer,Rolf;Wright,Samuel;Xiao,Jianying;Zokian,Hratch;Balkovec,JamesM.[BioorganicandMedicinalChemistryLetters,2008,vol.18,#11,p.3405-3411]

Literature fold

Title: Synthesis and cloxacillin antimicrobial enhancement of 2-methylsulfonylimidazolyl-1,4-dihydropyridine derivatives.

Journal: Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences20100101

Title: Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.

Journal: Arthritis research & therapy20050101

Title: Genetic algorithm applied to the selection of factors in principal component-artificial neural networks: application to QSAR study of calcium channel antagonist activity of 1,4-dihydropyridines (nifedipine analogous).

Journal: Journal of chemical information and computer sciences20030101

Title: Quantitative structure-activity relationship study of recently synthesized 1,4-dihydropyridine calcium channel antagonists. Application of the Hansch analysis method.

Journal: Archiv der Pharmazie20021201

Building Blocks More >
220389-76-4
220389-76-4
2-Ethoxy-1,3-thiazole-5-carbaldehyde
AA00CG49 | MFCD09693783
39662-63-0
39662-63-0
5-ETHOXY-2-PYRROLIDINONE
AA00CH9O | MFCD03426969
351317-28-7
351317-28-7
Ethyl 4-fluoro-3-hydroxybenzoate
AA00CHND | MFCD12025283
380190-11-4
380190-11-4
3-((4-Fluorophenyl)amino)propanenitrile
AA00CI58 | MFCD01910095
42116-55-2
42116-55-2
Methyl 3-([(tert-butoxy)carbonyl]amino)propanoate
AA00CIPR | MFCD12198407
34883-08-4
34883-08-4
4-Methoxy-6-methylsalicylaldehyde
AA00CIVP | MFCD06496263
3222-53-5
3222-53-5
3-Pyridinecarboxylicacid,5-ethyl-(9CI)
AA00CJ6Y | MFCD11043003
338454-98-1
338454-98-1
4-(4-Bromo-2-fluorobenzyl)morpholine
AA00CJNX | MFCD12022322
339029-56-0
339029-56-0
1-(3-Chlorophenyl)-4-hydroxy-6-oxo-1,6-dihydro-3-pyridazinecarboxylic acid
AA00CJZH | MFCD00141204
38113-86-9
38113-86-9
Methyl 4-hydroxyquinoline-3-carboxylate
AA00CK2Z | MFCD08436132
Submit
© 2017 AA BLOCKS, INC. All rights reserved.